CUSIP 89532M101COMTRVIQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
182 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Nea Management Company, LLC | 13.22M | $165.54M | 0 | Held |
| 2 | Frazier Life Sciences Management, L.P. | 10.26M | $128.45M | 0 | Held |
| 3 | Blackrock, Inc. | 10.13M | $126.78M | +225.1K | Added |
| 4 | Fmr LLC | 6.50M | $81.38M |
| +3.20M |
| Added |
| 5 | Vanguard Group Inc | 6.43M | $80.56M | +607.7K | Added |
| 6 | Vivo Capital, LLC | 5.09M | $63.79M | 0 | Held |
| 7 | Marshall Wace, LLP | 4.58M | $57.35M | −261.2K | Reduced |
| 8 | Rubric Capital Management LP | 3.77M | $47.16M | −4.77M | Reduced |
| 9 | Wellington Management Group LLP | 3.40M | $42.62M | +150.1K | Added |
| 10 | Mpm Bioimpact LLC | 3.29M | $41.15M | −119.9K | Reduced |
See every fund holding Trevi Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders